GlassScriptPhysician profile
James Benjamin Thornton
NPI 1891113486
$3,264.09
in general payments reported to CMS, 2019-2025
43 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $149 · 2022: $231 · 2023: $863 · 2024: $600 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $731.64 | 2020-2025 | Qulipta, Botox, Ubrelvy |
| Ucb, INC. | $442.29 | 2019-2024 | Briviact, Rystiggo, Fintepla |
| Amgen INC. | $301.35 | 2019-2025 | Uplizna |
| Boston Scientific Corporation | $176.09 | 2019-2023 | Watchman Access System |
| Chiesi USA, INC. | $117.76 | 2019-2025 | Cleviprex |
| Pfizer INC. | $111.32 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $110.71 | 2019-2023 | Xarelto |
| Csl Behring | $108.58 | 2019-2025 | Hizentra |
| Novartis Pharmaceuticals Corporation | $81.27 | 2019-2025 | |
| Avanir Pharmaceuticals, INC. | $73.67 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $71.97 | 2023 | Andexxa |
| Alexion Pharmaceuticals, INC. | $60.69 | 2019-2024 | Ultomiris |
| Alnylam Pharmaceuticals INC. | $59.77 | 2019-2025 | Onpattro |
| Banner Life Sciences, LLC | $51.21 | 2023-2024 | |
| Eisai INC. | $49.64 | 2019-2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.